Medicina | Free Full-Text | Utility of PIVKA-II and AFP in Differentiating Hepatocellular Carcinoma from Non-Malignant High-Risk Patients
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma | BMC Cancer | Full Text
Pivka-II Monoclonal Antibody (DCP tumor marker) - China Pivka-II, Antibody | Made-in-China.com
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma | BMC Cancer | Full Text
Elecsys® PIVKA-II
IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
pivka_ii_pair_recommendations_1.jpg
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
PIVKA-II is a candidate marker for monitoring the effects of the oral anticoagulant warfarin. | Semantic Scholar
PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients
The Relationship between Serum PIVKA-II Levels and the Severity of... | Download Table
Premium Photo | Pivka ii or protein induced by vitamin k ii test a screening marker for hepatocellular carcinoma
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: a pilot study
Frontiers | Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma
Significance of PIVKA‑II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus‑associated hepatocellular carcinoma
Elecsys® PIVKA-II
PIVKA-II, a biomarker of liver cells for the management of hepatocellular carcinoma (HCC) | Fujirebio
Epitope characterization of an anti-PIVKA-II antibody and evaluation of a fully automated chemiluminescent immunoassay for PIVKA-II - ScienceDirect
Comparison of AFP and PIVKA-II level in different grades and stages of... | Download Table
PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma | PLOS ONE
Significance of PIVKA‑II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus‑associated hepatocellular carcinoma
Development and evaluation of analytical performance of a fully automated chemiluminescent immunoassay for protein induced by vitamin K absence or antagonist II - ScienceDirect
Clinical course of the patient. a Tumor markers (AFP, PIVKA-II)... | Download Scientific Diagram
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
